Elbit Imaging Ltd. (EMITF)
OTCMKTS: EMITF · Delayed Price · USD
0.850
0.00 (0.00%)
Apr 15, 2024, 10:05 AM EDT - Market closed

Company Description

Elbit Imaging Ltd., together with its subsidiaries, develops, produces, and markets therapeutic medical systems for performing non-invasive treatments on the human body in Israel and internationally.

The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body.

It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases.

In addition, the company is involved in the sale of plots and villas in India. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007.

Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Petach Tikva, Israel.

Elbit Imaging Ltd.
Country Israel
Founded 1996
IPO Date Nov 27, 1996
Industry Medical Devices
Sector Healthcare
Employees 3
CEO Ron Hadassi BA, LL.B, MBA

Contact Details

Address:
No 3 St. Shimshon
Petach Tikva, L3 4952801
Israel
Phone 03-6086000

Stock Details

Ticker Symbol EMITF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001027662
CUSIP Number M37605124
ISIN Number IL0010811169
SIC Code 6512

Key Executives

Name Position
Ron Hadassi BA, LL.B, MBA Chief Executive Officer and Chairman of the Board of Directors
Ricky Steiner Chief Financial Officer
Tzipi Siani-Amosi Chief Financial Officer of Elbit Medical
Dr. Maurice R. Ferre M.D. Chairman of the Board and Chief Executive Officer of Insightec Ltd
Jun Tao Chief Commercial Officer of InSightec Ltd

Latest SEC Filings

Date Type Title
Sep 20, 2019 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 20, 2019 SC 13G Statement of acquisition of beneficial ownership by individuals
Aug 8, 2019 15F-12G Filing
Aug 8, 2019 6-K Report of foreign issuer
Aug 7, 2019 EFFECT Notice of Effectiveness
Aug 7, 2019 6-K Report of foreign issuer
Aug 6, 2019 POS AM Post-Effective amendments for registration statement
Jul 25, 2019 6-K Report of foreign issuer
Jul 10, 2019 6-K Report of foreign issuer
Jul 8, 2019 6-K Report of foreign issuer